Abraldes JG - Search Results

1

Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis.

Turnes J, Garcia-Pagan JC, Abraldes JG, Hernandez-Guerra M, Dell'Era A, Bosch J. Turnes J, et al. Among authors: abraldes jg. Am J Gastroenterol. 2006 Mar;101(3):506-12. doi: 10.1111/j.1572-0241.2006.00453.x. Am J Gastroenterol. 2006. PMID: 16542287 Clinical Trial.

2

Somatostatin and analogues in portal hypertension.

Abraldes JG, Bosch J. Abraldes JG, et al. Hepatology. 2002 Jun;35(6):1305-12. doi: 10.1053/jhep.2002.33469. Hepatology. 2002. PMID: 12029614 Review. No abstract available.

3

Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.

Bañares R, Moitinho E, Matilla A, García-Pagán JC, Lampreave JL, Piera C, Abraldes JG, De Diego A, Albillos A, Bosch J. Bañares R, et al. Among authors: abraldes jg. Hepatology. 2002 Dec;36(6):1367-73. doi: 10.1053/jhep.2002.36947. Hepatology. 2002. PMID: 12447861 Clinical Trial.

4

Novel approaches to treat portal hypertension.

Abraldes JG, Bosch J. Abraldes JG, et al. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S232-41. doi: 10.1046/j.1440-1746.17.s3.6.x. J Gastroenterol Hepatol. 2002. PMID: 12472942 Review. No abstract available.

5

Acute propranolol administration effectively decreases portal pressure in patients with TIPS dysfunction. Transjugular intrahepatic portosystemic shunt.

Bellis L, Moitinho E, Abraldes JG, Graupera M, García-Pagán JC, Rodés J, Bosch J. Bellis L, et al. Among authors: abraldes jg. Gut. 2003 Jan;52(1):130-3. doi: 10.1136/gut.52.1.130. Gut. 2003. PMID: 12477774 Free PMC article.

6

Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.

Bellis L, Berzigotti A, Abraldes JG, Moitinho E, García-Pagán JC, Bosch J, Rodés J. Bellis L, et al. Among authors: abraldes jg. Hepatology. 2003 Feb;37(2):378-84. doi: 10.1053/jhep.2003.50053. Hepatology. 2003. PMID: 12540788 Clinical Trial.

7

Current management of portal hypertension.

Bosch J, Abraldes JG, Groszmann R. Bosch J, et al. Among authors: abraldes jg. J Hepatol. 2003;38 Suppl 1:S54-68. doi: 10.1016/s0168-8278(02)00430-0. J Hepatol. 2003. PMID: 12591186 Review. No abstract available.

8

Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.

Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodés J, Bosch J. Abraldes JG, et al. Hepatology. 2003 Apr;37(4):902-8. doi: 10.1053/jhep.2003.50133. Hepatology. 2003. PMID: 12668985

9

Effects of the V1a vasopressin agonist F-180 on portal hypertension-related bleeding in portal hypertensive rats.

Morales J, Moitinho E, Abraldes JG, Fernández M, Bosch J. Morales J, et al. Among authors: abraldes jg. Hepatology. 2003 Dec;38(6):1378-83. doi: 10.1016/j.hep.2003.09.023. Hepatology. 2003. PMID: 14647048

10

Increased CD11b neutrophil expression in Budd-Chiari syndrome or portal vein thrombosis secondary to polycythaemia vera.

Alvarez-Larrán A, García-Pagán JC, Abraldes JG, Arellano E, Reverter JC, Bosch J, Cervantes F. Alvarez-Larrán A, et al. Among authors: abraldes jg. Br J Haematol. 2004 Feb;124(3):329-35. doi: 10.1046/j.1365-2141.2003.04770.x. Br J Haematol. 2004. PMID: 14717780 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

313 results

Search Page

Filters